Parkinson’s Disease Can Be Stopped With These Easy Methods

  • Sep 12 , 2017

Parkinson’s disease is the second most common neuro-degenerative disorder which impacts the overall movement of the person. As it will affect the neuro system of the body, the person might lose muscle control which can cause trembling of the limbs and head while at rest, stiffness, slowness, and impaired balance.

The impairment in the body may vary from one person to another and with time, the person might find it difficult to talk, walk, and complete basic tasks. There are many people who are affected with the disorder and live long productive lives but there are others who become disabled quite quickly.

Our brain works on the electric signals which are transferred by different body parts to perform basic tasks. There is a substance called dopamine which acts as a messenger between two brain areas which is used to produce smooth and controlled movements. The person who is suffering from the disorder is due to the lack of the dopamine in the brain. There will be no paired communication between two different parts which can cause impaired movement in the person.

Photo Courtesy: NetDoctor

Risk factors for Parkinson’s disease:

  • Age is one of the largest risk factors as the person who is above 60 years develops more chances of suffering from the disorder as most of the cases which have been registered were the people of same age group.
  • Gender also plays a vital role as men are 2 times more affected with the disorder compared to women.
  • If someone in your family suffered or suffering from the disorder, there are chances that you might also develop the symptoms in later years.

According to the latest study, it is possible to stop the progression of Parkinson’s disorder with the same drug which is normally used in type 2 diabetes. The drugs which are available in the market for the disorder are used to prevent the symptoms of the disorder but they can’t stop the brain cells from dying. The trail was conducted on the 62 patients and it was concluded that the new drug which was used on the patients halted the progression of the disorder.

“There's absolutely no doubt the most important unmet need in Parkinson's is a drug to slow down disease progression, it's unarguable,” Prof Tom Foltynie, one of the researchers, told the BBC. In the disorder, different parts of the brain start getting damaged and it loses the cells which produce dopamine to cause tremor. This will also lead to the difficulty in the movements and with more progression; the person will also lose its memory.

There are many therapies by which doctors can boost the production of dopamine levels in the brain, but the process doesn’t stop the progression of the disorder and with time it can lead to the death of the brain.

In the first session, half of the patients were given the diabetes drug and others drug for Parkinson’s disorder. All of them stayed on the usual medication which is recommended while suffering from the disease. After three months, half of the population with diabetes drug showed progress as they were better off as compared to the ones which were on regular treatment.

Prof Foltynie told BBC, “This is the first clinical trial in actual patients with Parkinson's where there has been anything like this size of the effect. “It gives us confidence exenatide is not just masking symptoms, it's doing something to the underlying disease.”

David Dexter, the deputy director of research at Parkinson’s UK, said, “The findings offer hope that drugs like exenatide can slow the course of Parkinson's – something no current treatment can do because Parkinson's can progress quite gradually, this study was probably too small and short to tell us whether exenatide can halt the progression of the condition, but it's certainly encouraging and warrants further investigation.”

According to the research, the trial should be conducted for a much longer period of time as the development of the disorder is slow and an effective drug should need to hold back the disease for years in order to make significant changes in the patients.